G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)
Condition(s):Cystic FibrosisLast Updated:June 30, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:June 30, 2021Completed
Condition(s):Severe SpasticityLast Updated:May 3, 2019Completed
Condition(s):Myeloproliferative Neoplasms of; Polycythemia Vera; Essential Thrombocythemia; MyelofibrosisLast Updated:April 12, 2017Completed
Condition(s):Ultrasound; CT Scans; MRIsLast Updated:March 20, 2017Completed
Condition(s):Orthostatic HypotensionLast Updated:June 8, 2021Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:October 14, 2016Completed
Condition(s):Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)Last Updated:November 2, 2016Completed
Condition(s):Symptomatic Orthostatic HypotensionLast Updated:June 9, 2021Completed
Condition(s):Type 2 Diabetes Mellitus (T2DM)Last Updated:July 19, 2017Terminated
Condition(s):RosaceaLast Updated:December 23, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.